Tarsus Pharmaceuticals
Price & Volume
Stats
See moreOpen | $74.77 |
Previous Close | $72.64 |
Day Range | $65.49-$74.77 |
52W Range | $53.89-$91.53 |
Market Cap | $3.4B |
Shares Short | 5M |
Financials
See moreRevenue (12 Mos) | $606.3M |
Revenue Growth (YoY) | 69.4% |
Gross Profit (12 Mos) | $501.2M |
Diluted EPS | -$1.08 |
News
See moreYahoo Finance • yesterday
Tarsus expects $715M-$730M 2026 XDEMVY sales while deferring Europe and Japan filings
Yahoo Finance • 2 months ago
Tarsus acquisition of Alkeus granted FTC early termination
Yahoo Finance • 3 months ago
Tarsus Pharmaceuticals To Acquire Alkeus Pharmaceuticals
Yahoo Finance • 4 months ago
Tarsus Pharmaceuticals Enters Retina Market With iRenix Deal, Adds IRX-101 to Pipeline
About
CEO | Dr. Bobak R. Azamian M.D. |
CFO | Mr. Jeffrey S. Farrow CPA |
Address | 17700 Laguna Canyon Road, Irvine, CA, United States, 92618 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 370 |